Filter programs:

38 Programs

  • Oncology Today with Dr Neil Love

    The Role of Oral Selective Estrogen Receptor Degraders in the Management of ER-Positive Metastatic Breast Cancer

    Explore program
    • October 2025 1 ABIM MOC, ABS MOC, CME 41min
      • P
      Patrick Neven
    • October 2025 1 ABIM MOC, ABS MOC, CME 42min
      • P
      Patrick Neven
  • Exploring the Potential Role of PROTAC Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer

    Explore program
    • October 2025 1.25 ABIM MOC, ABS MOC 58min
      • E
      Erika Hamilton
    • October 2025 0.75 ABIM MOC, ABS MOC 29min
      • E
      Erika Hamilton
  • Webinar Proceedings

    Current and Future Integration of Antibody-Drug Conjugates into the Management of Metastatic Breast Cancer

    Explore program
  • Striving for Consensus

    Clinical Investigators Review the Current and Future Role of Oral SERDs in the Care of Patients with ER-Positive Metastatic Breast Cancer

    Explore program
    • October 2025 2.75 ABIM MOC, ABS MOC, CME 2h 30min
      • F
      • H
        Hope S Rugo, MD
      • R
      • +1
      Francois-Clement Bidard